Financhill
Back

Kineta Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
45

KA
Kineta

Last Price:
0.55
Seasonality Move:
-32.75%
Sell
19

NBY
NovaBay Pharmaceuticals

Last Price:
2.13
Seasonality Move:
-12.93%
Sell
45
Kineta (KA) is a Sell

Is Kineta a Buy, Sell or Hold?

  • The current Kineta [KA] share price is $0.63. The Score for KA is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • KA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $2.10. The Score for NBY is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

KA Stock Price Chart

What is Kineta's stock price today?

  • The Kineta share price today is $0.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KA is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $2.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

KA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 57.55 Buy
Chaikin Money Flow: -119884 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.43 - 0.59) Buy
Bollinger Bands (100): (0.15 - 1.73) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.42 Sell
Relative Strength Index (14 RSI): 35.81 Sell
Chaikin Money Flow: -120877 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.21 - 4.55) Sell
Bollinger Bands (100): (2.85 - 5.07) Sell

KA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.58 Buy
20-day SMA: 0.52 Buy
50-day SMA: 0.53 Buy
200-day SMA: 2.14 Sell
8-day EMA: 0.6 Buy
20-day EMA: 0.55 Buy
50-day EMA: 0.63 Buy
200-day EMA: 1.84 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.33 Sell
20-day SMA: 2.97 Sell
50-day SMA: 3.21 Sell
200-day SMA: 7.59 Sell
8-day EMA: 2.34 Sell
20-day EMA: 2.79 Sell
50-day EMA: 3.33 Sell
200-day EMA: 14.4 Sell

Kineta Earnings Growth & KA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.46 per share, and a decrease next year of $0.00 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $13.48 per share, an increase next quarter of $0.35 per share, an increase this year of $74.90 per share, and an increase next year of $5.60 per share.

Kineta Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):